To examine the relationship between SDH5 and the RT response, we initiated an analytical, observational, open, retrospective study (ChiCTR1800014878) involving 208 patients with stage III lung cancer who were ready to receive RT. The gene discussed is SDHAF2; the disease is lung cancer.